JPS49102827A - - Google Patents

Info

Publication number
JPS49102827A
JPS49102827A JP48015702A JP1570273A JPS49102827A JP S49102827 A JPS49102827 A JP S49102827A JP 48015702 A JP48015702 A JP 48015702A JP 1570273 A JP1570273 A JP 1570273A JP S49102827 A JPS49102827 A JP S49102827A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48015702A
Other languages
Japanese (ja)
Other versions
JPS5518692B2 (fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DK135268D priority Critical patent/DK135268A/da
Application filed filed Critical
Priority to JP1570273A priority patent/JPS5518692B2/ja
Priority to GB521374A priority patent/GB1443662A/en
Priority to DK69374A priority patent/DK135268B/da
Publication of JPS49102827A publication Critical patent/JPS49102827A/ja
Publication of JPS5518692B2 publication Critical patent/JPS5518692B2/ja
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP1570273A 1973-02-09 1973-02-09 Expired JPS5518692B2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DK135268D DK135268A (fr) 1973-02-09
JP1570273A JPS5518692B2 (fr) 1973-02-09 1973-02-09
GB521374A GB1443662A (en) 1973-02-09 1974-02-05 Insulin-dispensing inserts
DK69374A DK135268B (da) 1973-02-09 1974-02-08 Fremgangsmåde til fremstilling af et ophthalmisk insulinpræparat.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1570273A JPS5518692B2 (fr) 1973-02-09 1973-02-09

Publications (2)

Publication Number Publication Date
JPS49102827A true JPS49102827A (fr) 1974-09-28
JPS5518692B2 JPS5518692B2 (fr) 1980-05-21

Family

ID=11896086

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1570273A Expired JPS5518692B2 (fr) 1973-02-09 1973-02-09

Country Status (3)

Country Link
JP (1) JPS5518692B2 (fr)
DK (2) DK135268B (fr)
GB (1) GB1443662A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483807A (en) * 1981-01-27 1984-11-20 Japan Atomic Energy Research Institute Process for producing a slow release composite
JPH01294633A (ja) * 1988-05-23 1989-11-28 Fujisawa Pharmaceut Co Ltd 点眼剤
US5049545A (en) * 1986-02-15 1991-09-17 Behringwerke Aktiengesellschaft Insulin derivatives, a process for their preparation, and their use

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164560A (en) 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4391797A (en) 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
DK179286D0 (da) * 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
US5227372A (en) * 1990-03-07 1993-07-13 Children's Medical Center Corporation Method for retaining ophthalmological agents in ocular tissues
EP2134351B1 (fr) 2007-03-13 2016-04-27 Nutrition 21, Inc. Procédés et compositions utilisés pour la libération prolongée de chrome
WO2009002867A2 (fr) 2007-06-26 2008-12-31 Nutrition 21, Inc. Forme posologique à unités multiples contenant un agent thérapeutique en combinaison avec un complément alimentaire
WO2012119007A1 (fr) 2011-03-01 2012-09-07 N21 Acquisition Holding, Llc Compositions d'insuline et de chrome pour traitement et prévention du diabète, de l'hypoglycémie et de troubles associés
CN109069532A (zh) 2016-02-11 2018-12-21 营养21有限责任公司 含铬组合物用于改善健康和健身

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483807A (en) * 1981-01-27 1984-11-20 Japan Atomic Energy Research Institute Process for producing a slow release composite
US5049545A (en) * 1986-02-15 1991-09-17 Behringwerke Aktiengesellschaft Insulin derivatives, a process for their preparation, and their use
JPH01294633A (ja) * 1988-05-23 1989-11-28 Fujisawa Pharmaceut Co Ltd 点眼剤

Also Published As

Publication number Publication date
GB1443662A (en) 1976-07-21
JPS5518692B2 (fr) 1980-05-21
DK135268C (fr) 1977-09-19
DK135268A (fr)
DK135268B (da) 1977-03-28

Similar Documents

Publication Publication Date Title
AU476761B2 (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU471343B2 (fr)
DK135268C (fr)
AU476714B2 (fr)
AU466283B2 (fr)
AU472848B2 (fr)
AU476696B2 (fr)
AU477823B2 (fr)
AU471461B2 (fr)
AU476873B1 (fr)
AR195311A1 (fr)
AR196382A1 (fr)
AU477824B2 (fr)
AR195948A1 (fr)
AR201432A1 (fr)
AR196123Q (fr)
AR196212Q (fr)
CH529674A4 (fr)
BG19270A1 (fr)
AU479458A (fr)
AU479420A (fr)